Cargando…
Experimental Evaluation of Anticancer Efficiency and Acute Toxicity of Anthrafuran for Oral Administration †
The new antitumor agent anthrafuran has demonstrated a consistent effect in murine tumor models when administered parenterally due to the simultaneous inhibition of multiple cellular targets such as topoisomerases I/II and protein kinases. In this study, we assessed the anticancer efficiency and acu...
Autores principales: | Shchekotikhin, Andrey E., Treshalina, Helen M., Treshchalin, Michael I., Pereverzeva, Eleonora R., Isakova, Helen B., Tikhomirov, Alexander S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281648/ https://www.ncbi.nlm.nih.gov/pubmed/32353946 http://dx.doi.org/10.3390/ph13050081 |
Ejemplares similares
-
Subchronic Toxicity Study of Oral Anthrafuran on Rabbits
por: Treshchalin, Michael I., et al.
Publicado: (2021) -
Evaluation of Toxic Properties of New Glycopeptide Flavancin on Rats
por: Treshchalin, Michael I., et al.
Publicado: (2022) -
Experimental Evaluation of the Hypersensitivity Reactions of a New Glycopeptide Antibiotic Flavancin in Animal Models
por: Treshchalin, Michael I., et al.
Publicado: (2023) -
Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity
por: Moiseenko, Elena I., et al.
Publicado: (2021) -
Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties
por: Olsufyeva, Evgenia N, et al.
Publicado: (2018)